Clinical trial
Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines
NCT06355219
Study timeline
Study start (actual)2010-01-01Date precision: day
Registry last updated2024-05-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitusunresolved
Obesityunresolved
Microvascular Diseaseunresolved
Macrovascular Diseaseunresolved
Major Adverse Cardiovascular Eventsunresolved
Nephropathyunresolved
Retinopathyunresolved
Heart Failureunresolved
All Cause Mortalityunresolved
Interventions
Sponsors & collaborators
Ali Aminianlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06355219 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.